» Articles » PMID: 17360728

An Epidemiological Study of Pulmonary Arterial Hypertension

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2007 Mar 16
PMID 17360728
Citations 281
Authors
Affiliations
Soon will be listed here.
Abstract

All hospitalisations for pulmonary arterial hypertension (PAH) in the Scottish population were examined to determine the epidemiological features of PAH. These data were compared with expert data from the Scottish Pulmonary Vascular Unit (SPVU). Using the linked Scottish Morbidity Record scheme, data from all adults aged 16-65 yrs admitted with PAH (idiopathic PAH, pulmonary hypertension associated with congenital heart abnormalities and pulmonary hypertension associated with connective tissue disorders) during the period 1986-2001 were identified. These data were compared with the most recent data in the SPVU database (2005). Overall, 374 Scottish males and females aged 16-65 yrs were hospitalised with incident PAH during 1986-2001. The annual incidence of PAH was 7.1 cases per million population. On December 31, 2002, there were 165 surviving cases, giving a prevalence of PAH of 52 cases per million population. Data from the SPVU were available for 1997-2006. In 2005, the last year with a complete data set, the incidence of PAH was 7.6 cases per million population and the corresponding prevalence was 26 cases per million population. Hospitalisation data from the Scottish Morbidity Record scheme gave higher prevalences of pulmonary arterial hypertension than data from the expert centres (Scotland and France). The hospitalisation data may overestimate the true frequency of pulmonary arterial hypertension in the population, but it is also possible that the expert centres underestimate the true frequency.

Citing Articles

The role of lactate metabolism and lactylation in pulmonary arterial hypertension.

Peng T, Lu J, Zheng X, Zeng C, He Y Respir Res. 2025; 26(1):99.

PMID: 40075458 PMC: 11905457. DOI: 10.1186/s12931-025-03163-3.


Early and Timely Surgery for an Atypical Form of Partial Anomalous Pulmonary Venous Return Enabled by a Rare Detection by Detailed Fetal Ultrasound.

Nagao H, Nemoto S Cureus. 2025; 17(1):e77798.

PMID: 39991368 PMC: 11842226. DOI: 10.7759/cureus.77798.


Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing.

Tarras E, Singh I, Kreiger J, Joseph P J Clin Med. 2025; 14(3).

PMID: 39941482 PMC: 11818252. DOI: 10.3390/jcm14030804.


Natural killer cells are decreased in systemic sclerosis and have diagnostic value for pulmonary arterial hypertension incorporation.

Guo R, Mi L, Gao J, Yang Y, Zhao M, He X Sci Rep. 2025; 15(1):5178.

PMID: 39939388 PMC: 11821854. DOI: 10.1038/s41598-025-89238-z.


Trends and levels of the global, regional, and national burden of pulmonary arterial hypertension from 1990 to 2021: findings from the global burden of disease study 2021.

Liu L, Li C, Cai J, Kong R, Wang Y, Wang Y Front Med (Lausanne). 2024; 11:1515961.

PMID: 39720660 PMC: 11666447. DOI: 10.3389/fmed.2024.1515961.